EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Engineering Strategies to Modulate the Gut Microbiome and Immune System

Kai Han iD, Jin Xu, Fang Xie, Julia Crowther iD, James J Moon iD

The Journal of Immunology · 15.01.2024 · 212 (2) · 208-215

DOI: 10.4049/jimmunol.2300480 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The Journal of Immunology, online erschienen am 15.01.2024. Verfasst von Kai Han und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Microbiota, Probiotics, Autoimmune Diseases. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCATS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiota, predominantly residing in the colon, is a complex ecosystem with a pivotal role in the host immune system. Dysbiosis of the gut microbiota has been associated with various diseases, and there is an urgent need to develop new therapeutics that target the microbiome and restore immune functions. This Brief Review discusses emerging therapeutic strategies that focus on oral delivery systems for modulating the gut microbiome. These strategies include genetic engineering of probiotics, probiotic-biomaterial hybrids, dietary fibers, and oral delivery systems for microbial metabolites, antimicrobial peptides, RNA, and antibiotics. Engineered oral formulations have demonstrated promising outcomes in reshaping the gut microbiome and influencing immune responses in preclinical studies. By leveraging these approaches, the interplay between the gut microbiota and the immune system can be harnessed for the development of novel therapeutics against cancer, autoimmune disorders, and allergies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeMicrobiotaProbioticsAutoimmune DiseasesHumansImmune SystemDysbiosis

Autor:innen und Institutionen

  • Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI.
  • State Key Laboratory of Natural Medicines, Department of Pharmaceutics, China Pharmaceutical University, Nanjing, China.
  • Biointerfaces Institute, University of Michigan, Ann Arbor, MI.
  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI.
  • Department of Chemical Engineering, University of Michigan, Ann Arbor, MI.

ORCID-Profile: Kai Han, Julia Crowther, James J Moon

Förderung

  • NINDS NIH HHS
  • NCATS NIH HHS
  • NIDDK NIH HHS
  • NIGMS NIH HHS
  • NIBIB NIH HHS
  • NIDCR NIH HHS
  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute

Zitieren

APA

Han, K., Xu, J., Xie, F., Crowther, J., & Moon, J. J. (2024). Engineering Strategies to Modulate the Gut Microbiome and Immune System. The Journal of Immunology, 212(2), 208-215. https://doi.org/10.4049/jimmunol.2300480

Vancouver

Han K, Xu J, Xie F, Crowther J, Moon JJ. Engineering Strategies to Modulate the Gut Microbiome and Immune System. The Journal of Immunology. 2024;212(2):208-215. doi:10.4049/jimmunol.2300480

BibTeX
@article{Han2024,
  author = {Han, Kai and Xu, Jin and Xie, Fang and Crowther, Julia and Moon, James J},
  title = {Engineering Strategies to Modulate the Gut Microbiome and Immune System},
  journal = {The Journal of Immunology},
  year = {2024},
  volume = {212},
  number = {2},
  pages = {208--215},
  doi = {10.4049/jimmunol.2300480}
}
Kostenlos starten →